The Artificial Leaf That Runs on CO2 and Could Replace Oil Chemistry

Cambridge researchers built an artificial leaf that converts CO2 into formate for over 24 hours, potentially reshaping how we make chemicals without oil.

The Artificial Leaf That Runs on CO2 and Could Replace Oil Chemistry
The Artificial Leaf That Runs on CO2 and Could Replace Oil Chemistry

Audio Briefing~1:09
Click play to listen to key points
Read transcript

Here’s what you need to know about the artificial leaf that could help replace oil in everyday chemistry.

Researchers at the University of Cambridge, led by Professor Erwin Reisner, have built a device that mimics how real leaves work, using sunlight and carbon dioxide to produce a useful chemical called formate. The breakthrough, published in November 2025, is that this version ran continuously for more than 24 hours, more than double what earlier versions could manage.

What makes this significant is the target it’s aimed at. The chemical industry, which makes everything from plastics to pharmaceuticals, is responsible for about 6 percent of global greenhouse gas emissions, and oil is not just the fuel, it’s the actual raw material. This device pulls carbon straight from CO2 instead.

The formate it produces is already used in drug manufacturing, so the output has a real home in existing supply chains.

If you want to follow this space, look into Cambridge’s Reisner Lab, because this is one of the more credible paths toward decarbonizing industrial chemistry.

What if the answer to one of chemistry’s biggest problems was already growing outside your window?

Every time you use a plastic container, swallow a pill, or pour cleaning fluid down a drain, you are touching the output of an industry that burns through oil to make its products. The global chemical sector accounts for roughly 6% of all greenhouse gas emissions, according to the Royal Society. That number has barely moved in decades.

But on November 19, 2025, a team led by Professor Erwin Reisner at the University of Cambridge published a study describing something that could begin to change that equation. They built an artificial leaf. And this one ran for more than 24 hours straight.

KEY TAKEAWAY
Cambridge’s artificial leaf converts CO2 into formate continuously for more than 24 hours using bacterial enzymes and sunlight, more than doubling the runtime of earlier versions and producing enough formate to drive a real pharmaceutical manufacturing step.

Why the Chemical Industry’s Oil Dependency Is a Climate Problem

Most people think of fossil fuels as a transportation problem. But oil and gas are also the raw material for an enormous range of everyday products. Plastics, solvents, fertilizers, pharmaceuticals — nearly all of them trace their origin back to petrochemicals.

Switching that supply chain away from oil is not a simple task. The chemical industry is deeply integrated with petroleum refining. Changing the feedstock means rebuilding the chemistry from scratch.

That is exactly what researchers like Reisner are trying to do. Instead of pulling carbon from oil, his artificial leaf pulls it from the air itself, specifically from CO2.

IMPORTANT
The chemical industry is responsible for about 6% of global greenhouse gas emissions. That makes it one of the hardest sectors to decarbonize, because carbon is not just the fuel — it is the raw material itself.

The concept of an artificial leaf is not new. Researchers at MIT, Harvard, and the University of Waterloo have all explored versions of the idea. Daniel Nocera, a Harvard professor, is widely credited with pioneering early artificial leaf technology that used sunlight and water to produce hydrogen fuel.

But the Cambridge team has pushed the concept in a different direction. Rather than producing hydrogen, their device targets CO2 directly and converts it into formate, a carbon-based chemical with real industrial uses.

Artificial Leaf Approach Output Key Feature
Nocera / Harvard (early model) Hydrogen fuel Split water using sunlight
MIT artificial leaf Chemical fuel Stored solar energy as fuel
University of Waterloo CO2-derived fuel Inexpensive CO2 conversion
Cambridge / Reisner (2025) Formate Bacterial enzymes, 24+ hour runtime

How Bacterial Enzymes Inside a Titanium Structure Make the Chemistry Work

The Cambridge device mimics photosynthesis, the process real leaves use to convert sunlight and CO2 into sugars. But instead of glucose, it makes formate. And instead of chlorophyll, it uses enzymes borrowed from bacteria.

Artificial Leaf Runtime and Output Comparison
Interactive data visualization
Earlier Artificial Leaf Versions
11
3
Cambridge Artificial Leaf (Nov 2025)
24
7
Industrial Scale Target
720
10

Runtime (hours)

Industrial Utility Score (1-10)

Source: University of Cambridge / Royal Society

Those enzymes were embedded into a porous titanium dioxide structure. Titanium dioxide is a well-studied photocatalyst, meaning it absorbs light and uses that energy to drive chemical reactions. The porous design gives the enzymes a stable home while allowing CO2 and water to flow through.

Technology Readiness Index
4.5/10
The Cambridge artificial leaf scores mid-range on technology readiness. It demonstrates continuous operation and real industrial output, but enzyme stability at scale, manufacturing cost, and long-term durability remain unresolved before commercial deployment.

“We call it an artificial leaf because it mimics real leaves and the process of photosynthesis. A leaf produces glucose and oxygen.”

— Professor Erwin Reisner, University of Cambridge

One of the most clever additions to this version was a helper enzyme called carbonic anhydrase. This enzyme manages how CO2 behaves in solution, keeping it available to the main catalytic enzymes rather than letting it escape or become unavailable. Think of it as a traffic controller for carbon molecules.

The whole system ran in a simple bicarbonate mixture, roughly comparable to sparkling water. There were no exotic solvents, no high-pressure chambers, no extreme temperatures. Just light, a carbon-rich liquid, and a carefully engineered biological scaffold.

24+ hrs
Continuous CO2-to-formate conversion runtime, more than double earlier versions
6%
Share of global greenhouse gas emissions from the chemical industry, per the Royal Society

Previous versions of the device had struggled with longevity. Enzymes are biological molecules, and they degrade. Earlier iterations ran for less than 12 hours before output declined significantly. The 2025 version ran more than twice as long, a meaningful engineering leap.

Formate Is Not Just a Lab Curiosity — It Has Real Industrial Value

Formate, or formic acid in its protonated form, is not a headline chemical. It does not have the name recognition of ethanol or hydrogen. But it is genuinely useful.

It is used as a preservative, a cleaning agent, and critically, as a building block in pharmaceutical manufacturing. The Cambridge team demonstrated that the formate their device produced was sufficient to drive a follow-on chemistry step used in drug synthesis. That is a significant proof of concept.

2x
The runtime improvement over earlier artificial leaf versions, achieved in the November 2025 Cambridge study

It also means the device is not just converting CO2 for the sake of it. The output connects to an existing supply chain. Pharmaceutical companies already use formate. If that formate could be sourced from captured CO2 rather than petrochemicals, the carbon math changes substantially.

Petrochemical Formate Production
VS
Artificial Leaf Formate Production
Proven at industrial scale
Uses CO2 and sunlight as inputs
Relies on fossil fuel feedstocks
Bacterial enzymes as catalysts, no oil required
Contributes to the chemical industry’s 6% global emissions share
Demonstrated 24+ hour continuous operation
Mature supply chains and established pricing
Formate output proven sufficient for pharmaceutical synthesis
VERDICT: Artificial leaf production is not yet cost-competitive at scale, but its carbon profile and feedstock independence give it a clear long-term structural advantage over petrochemical routes.

Formate also has potential as a hydrogen carrier, a way to store and transport hydrogen energy in a safer, more stable chemical form. That opens a second pathway for the technology beyond direct chemical production.

What Would You Do?

You run a small pharmaceutical ingredient company. A research team offers you early access to an artificial leaf system that produces formate from CO2 using sunlight. It works in the lab but has never been deployed at industrial scale. Your current formate supplier uses petrochemical feedstocks.

Calculated Risk
You gain early insight into real-world performance and potential cost savings, but face engineering unknowns and upfront costs.

Conservative
You avoid early-stage risk, but may lose competitive advantage if the technology becomes standard and early adopters lock in better pricing.

High Risk
High risk of supply disruption if the system underperforms at scale. The technology has only proven 24-hour runtime in lab conditions.
From Sunlight to Pharmaceutical Ingredient: How the Device Works
Step 1: Light hits the titanium dioxide scaffold
The porous TiO2 structure absorbs sunlight and generates the energy needed to drive the reaction.
Step 2: Carbonic anhydrase manages CO2 availability
The helper enzyme keeps dissolved CO2 accessible to the main catalytic enzymes rather than letting it escape.
Step 3: Bacterial enzymes convert CO2 to formate
The main enzymes, derived from bacteria, catalyze the reduction of CO2 into formate continuously for more than 24 hours.
Step 4: Formate feeds into pharmaceutical chemistry
The formate output is sufficient to drive a follow-on synthesis step used in drug manufacturing, validating real industrial utility.

What Scaling This Technology Would Actually Require

Laboratory demonstrations and industrial deployment are separated by a vast distance. The Cambridge device works at a small scale, under controlled conditions, with carefully prepared enzymes. Making it work at the scale of a chemical plant is a different challenge entirely.

Enzymes are expensive to produce and sensitive to environmental conditions. Titanium dioxide is relatively abundant, but engineering it into precise porous structures at scale adds cost and complexity. The bicarbonate solution the device uses is simple, but managing large volumes of it introduces new engineering problems.

Artificial Leaf Runtime: Then vs Now
EARLIER VERSIONS
Previous artificial leaf devices using enzyme-based catalysts ran for fewer than 12 hours before output declined significantly. The enzyme degradation problem limited practical usefulness and made continuous industrial operation impossible.

CAMBRIDGE 2025 VERSION
By adding carbonic anhydrase as a helper enzyme and refining the porous titanium dioxide scaffold, the Cambridge team extended runtime to more than 24 hours, more than doubling previous performance and producing formate at levels sufficient to drive real pharmaceutical chemistry.

IMPORTANT
The 24-hour runtime is a major step forward, but enzymes degrade over time. Long-term stability across weeks or months of continuous operation remains one of the key challenges before this technology could enter industrial use.

None of this means the research is not meaningful. Every technology that eventually reached industrial scale started as a laboratory proof of concept. The question is whether the underlying chemistry is sound enough to justify the engineering investment needed to scale it.

The Cambridge team’s work suggests the chemistry is increasingly solid. The runtime improvement, the use of a helper enzyme to manage CO2, and the demonstrated connection to pharmaceutical manufacturing all point toward a research program that is methodically closing the gap between concept and application.

Other research groups are working on related approaches. The broader field of solar-driven chemical synthesis has attracted significant academic attention over the past decade. Cambridge is not alone in this race, but the November 2025 study represents one of the most complete demonstrations of a continuous, enzyme-driven CO2 conversion system to date.

The chemical industry will not abandon oil overnight. The infrastructure, the supply chains, and the economic incentives are all deeply entrenched. But the direction of travel is becoming clearer. If a device sitting in a bicarbonate solution can turn CO2 into pharmaceutical ingredients using nothing but sunlight and bacterial enzymes, the question is no longer whether this chemistry is possible. The question is how long it takes to make it cheap enough to matter.

Real leaves have been doing a version of this for 500 million years. The artificial version just ran for 24 hours. That gap is closing faster than most people realize.

Frequently Asked Questions

What is an artificial leaf and how does the Cambridge version work?
An artificial leaf is a device that mimics photosynthesis to convert CO2 and water into useful chemicals using sunlight. The Cambridge version uses bacterial enzymes embedded in a porous titanium dioxide structure, with a helper enzyme called carbonic anhydrase managing CO2 availability, to convert CO2 into formate continuously for more than 24 hours.
What is formate and why is it useful?
Formate is a carbon-based chemical used as a preservative, cleaning agent, and building block in pharmaceutical manufacturing. The Cambridge device produced enough formate to drive a follow-on chemistry step used in drug synthesis, demonstrating real industrial potential.
How long did the artificial leaf run in the 2025 Cambridge study?
The device ran for more than 24 hours continuously, which is more than twice the runtime of earlier versions of the technology.
Why does the chemical industry’s CO2 footprint matter?
According to the Royal Society, the chemical industry is responsible for about 6% of global greenhouse gas emissions. Unlike transportation, the industry uses fossil fuels as raw materials, not just energy, making decarbonization particularly complex.
Who led the artificial leaf research published in November 2025?
The research was led by Professor Erwin Reisner at the University of Cambridge, published on November 19, 2025.
3007 articles

Editorial Team

The Editorial Team is the named, credentialed group responsible for every article on this site. Each piece is researched by a section editor, reviewed by a credentialed practitioner where the topic warrants it, and signed off by the Editor in Chief before publication. The corrections process is public; named editors are accountable.

Leave a Reply

Your email address will not be published. Required fields are marked *